MedTrace Logo

Process Versus Outcomes Incentives for Lipid Management

NCT02246959 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 764

Last updated 2019-02-26

No results posted yet for this study

Summary

In a 4-arm, randomized controlled trial, we will evaluate the relative effectiveness and cost-effectiveness of improving cholesterol levels among participants who are at high risk of CVD and who have elevated LDL cholesterol levels by testing process versus outcomes financial incentives. Participants will use electronic pill bottles that continuously monitor statin adherence. The primary outcome will be change in LDL cholesterol over 12 months.

Conditions

Interventions

BEHAVIORAL

Process Incentive

Daily sweepstake conditional on daily medication adherence

BEHAVIORAL

Outcome Incentive

Incentives conditional on LDL cholesterol reduction

Sponsors & Collaborators

Principal Investigators

  • Kevin Volpp, MD, PhD · University of Pennsylvania

  • Peter Reese, MD, MSCE · University of Pennsylvania

  • Iwan Barankay, PhD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2018-05-31
Completion
2018-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02246959 on ClinicalTrials.gov